Helena Čelešnik

7PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 14, 2026
Cannabinoids in Combination with Conventional Breast Cancer Therapies: Mechanistic Insights and the Gap to Clinical Translation.

Anja Bizjak, Uroš Potočnik, Helena Čelešnik

|Sep 28, 2024
Isoform-Level Transcriptome Analysis of Peripheral Blood Mononuclear Cells from Breast Cancer Patients Identifies a Disease-Associated RASGEF1A Isoform.

Helena Čelešnik, Mario Gorenjak, Martina Krušič

|Jun 27, 2023
Gene Expression Profiles of Methyltransferases and Demethylases Associated with Metastasis, Tumor Invasion, CpG73 Methylation, and HPV Status in Head and Neck Squamous Cell Carcinoma.

Larisa Goričan, Tomaž Büdefeld, Helena Čelešnik

|Feb 25, 2023
Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer.

Helena Čelešnik, Uroš Potočnik

|Feb 15, 2022
Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer.

Helena Čelešnik, Uroš Potočnik

|Jan 11, 2022
MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines.

Kristijan Skok, Lidija Gradišnik, Helena Čelešnik

Pageof 2

Frequent Collaborators

6 joint publications

Uroš Potočnik

2 joint publications

Mario Gorenjak

2 joint publications

Monika Sobočan

1 joint publications

Kristijan Skok